Interpace Biosciences, Inc. (IDXG)
1.85
+0.03
(+1.65%)
USD |
OTCM |
Feb 12, 16:00
Interpace Biosciences Cash from Investing (Quarterly) : -0.117M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| FONAR Corp. | -2.367M |
| Thermo Fisher Scientific, Inc. | 891.00M |
| XWELL, Inc. | 1.715M |
| Hypha Labs, Inc. | -0.0312M |
| Veracyte, Inc. | 48.26M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.938M |
| Cash from Financing (Quarterly) | -0.90M |
| Free Cash Flow | 4.43M |
| Free Cash Flow Per Share (Quarterly) | 0.0658 |
| Free Cash Flow to Equity (Quarterly) | 2.713M |
| Free Cash Flow to Firm (Quarterly) | 1.851M |
| Free Cash Flow Yield | 14.91% |